ArticleMalaysian family physician : the official journal of the Academy of Family Physicians of Malaysia2025
A retrospective multicentre study on the outcomes of the pharmacist-managed Diabetes Medication Therapy Adherence Clinic programme in primary health clinics across Johor, Malaysia.
Article in Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The Diabetes Medication Therapy Adherence Clinic (DMTAC) programme is an ambulatory care service provided by trained pharmacists in collaboration with doctors. It supports improved glycaemic control by enhancing patients' understanding and treatment adherence through education. Methods: Patients enrolled in the DMTAC programme in all 84 health clinics in Johor from January 2016 to December 2017 were included. Demographic characteristics, diabetic and medication history, current treatments, comorbidities and therapeutic outcomes (glycosylated haemoglobin A1c [HbAlc] level and lipid profile) were collected and reviewed retrospectively. Baseline HbAlc levels and lipid profiles were taken from patients' medical records during their first visits and post-intervention values from follow-up data, including the most recent information documented during the last DMTAC pharmacist visit before December 2017. Results: A total of 1107 patients (693 women and 414 men) with type 2 diabetes mellitus aged 24-88 years were included. The mean HbA1c level significantly decreased by 0.92±1.94%. The mean total cholesterol (-0.27 mmol/L), low-density lipoprotein (-0.31 mmol/L) and triglyceride levels (-0.14 mmol/L) slightly but significantly decreased. Both systolic and diastolic blood pressures also showed small but significant reductions from 142/81 mmHg pre-intervention to 137/79 mmHg postintervention. The patients' understanding scores improved from 87.94% to 98.55% after their fourth DMTAC pharmacist visit. Conclusion: The DMTAC programme in public health clinics across Johor, Malaysia, significantly improves HbA1c levels, fasting blood glucose levels, lipid profiles, BPs and medication understanding, with DMTAC pharmacists playing a key role in supporting multidisciplinary teams through targeted interventions and counselling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.